tiprankstipranks
Ember Therapeutics Inc (EMBT)
OTHER OTC:EMBT
US Market
Holding EMBT?
Track your performance easily

Ember Therapeutics (EMBT) Stock Price & Analysis

4 Followers

EMBT Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Financials

Annual

EMBT FAQ

What was Ember Therapeutics Inc’s price range in the past 12 months?
Currently, no data Available
What is Ember Therapeutics Inc’s market cap?
Currently, no data Available
When is Ember Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ember Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Ember Therapeutics Inc overvalued?
According to Wall Street analysts Ember Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Ember Therapeutics Inc pay dividends?
    Ember Therapeutics Inc does not currently pay dividends.
    What is Ember Therapeutics Inc’s EPS estimate?
    Ember Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Ember Therapeutics Inc have?
    Ember Therapeutics Inc has 3,985,000 shares outstanding.
      What happened to Ember Therapeutics Inc’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Ember Therapeutics Inc?
      Currently, no hedge funds are holding shares in EMBT
      ---

      Ember Therapeutics Stock Smart Score

      10
      Unlock Smart Score
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      Ember Therapeutics Inc

      Ember Therapeutics Inc is engaged in the healthcare sector. It is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies. It looks to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Cerus
      Cyclacel Pharmaceuticals
      Geron
      Karyopharm Therapeutics
      Popular Stocks
      ---
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis